Acumen Pharmaceuticals Inc.

Plus: Arnav Mehta joins The Column Group as venture partner and an update from Acumen

Plus: NextPoint names Eisai vet Cheung CEO, Love joins Gilead board and updates from Acumen, Maxion, EnteroBiotix, Remix

Ten biopharmas raised a combined $2.1B in July, of which argenx was responsible for nearly $1.3B

Plus: FDA approves AZ and Sanofi’s RSV prophylactic, and updates from Apellis, J&J, Travere and Acumen

β-amyloid therapies in development don’t rely on the presence of Aβ*56, the specific oligomer species in question

Two and half decades after it was founded, Acumen goes public with revived amyloid therapy